Literature DB >> 24746470

Systemic identification of estrogen-regulated genes in breast cancer cells through cap analysis of gene expression mapping.

Ryonosuke Yamaga1, Kazuhiro Ikeda2, Joost Boele3, Kuniko Horie-Inoue2, Ken-Ichi Takayama4, Tomohiko Urano4, Kaoru Kaida5, Piero Carninci5, Jun Kawai6, Yoshihide Hayashizaki6, Yasuyoshi Ouchi7, Michiel de Hoon5, Satoshi Inoue8.   

Abstract

To explore the estrogen-regulated genes genome-widely in breast cancer, cap analysis of gene expression (CAGE) sequencing was performed in MCF-7 cells under estrogen treatment. Estrogen-regulated expressional changes were found in 1537 CAGE tag clusters (TCs) (⩾1.5 or ⩽0.66-folds). Among them, 15 TCs were situated in the vicinity of (⩽10 kb) reported estrogen receptor-binding sites. Knockdown experiments of the 15 TC-associated genes demonstrated that the genes such as RAMP3, ISOC1 and GPRC5C potentially regulate the growth or migration of MCF-7 cells. These results suggest that CAGE sequencing will reveal novel estrogen target genes in breast cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cap analysis of gene expression; Estrogen; Transcriptome

Mesh:

Substances:

Year:  2014        PMID: 24746470     DOI: 10.1016/j.bbrc.2014.04.033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology.

Authors:  Kazuhiro Ikeda; Kuniko Horie-Inoue; Satoshi Inoue
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

2.  Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production.

Authors:  Yulia Kushnareva; Ian T Mathews; Alexander Y Andreyev; Gokmen Altay; Cecilia S Lindestam Arlehamn; Vijayanand Pandurangan; Roland Nilsson; Mohit Jain; Alessandro Sette; Bjoern Peters; Sonia Sharma
Journal:  J Immunol       Date:  2021-02-05       Impact factor: 5.422

3.  Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3β pathway.

Authors:  Bo Gao; Lianmei Zhao; Feifei Wang; Hanyu Bai; Jing Li; Meng Li; Xuhua Hu; Jian Cao; Guiying Wang
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

4.  Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.

Authors:  J Astor Ankney; Ling Xie; John A Wrobel; Li Wang; Xian Chen
Journal:  BMC Med Genomics       Date:  2019-05-30       Impact factor: 3.063

5.  Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development.

Authors:  Jinghan Shi; Fujun Yang; Nanfeng Zhou; Yan Jiang; Yanfeng Zhao; Junjie Zhu; Arsela Prelaj; Jyoti Malhotra; Nicola Normanno; Elisa Danese; Andrés F Cardona; Xuan Hong; Gening Jiang; Xiao Song
Journal:  Transl Lung Cancer Res       Date:  2021-03

6.  A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer.

Authors:  Courtney D Dill; Eric B Dammer; Ti'ara L Griffen; Nicholas T Seyfried; James W Lillard
Journal:  iScience       Date:  2021-04-19

7.  Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.

Authors:  Yusuke Yoshioka; Manami Shimomura; Keigo Saito; Hideshi Ishii; Yuichiro Doki; Hidetoshi Eguchi; Tetsuya Nakatsura; Takao Itoi; Masahiko Kuroda; Masaki Mori; Takahiro Ochiya
Journal:  Cancer Sci       Date:  2022-08-11       Impact factor: 6.518

8.  Impact of microRNA-130a on the neutrophil proteome.

Authors:  Corinna Cavan Pedersen; Jan Christian Refsgaard; Ole Østergaard; Lars Juhl Jensen; Niels Henrik Helweg Heegaard; Niels Borregaard; Jack Bernard Cowland
Journal:  BMC Immunol       Date:  2015-11-25       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.